表紙:寒冷疼痛治療の世界市場 (~2025年):製品別の冷痛治療市場 (OTC (ジェル・クリーム・パッチ・ラップ・パッド)・処方デバイス (電動・非電動)・用途 (筋骨格・術後・スポーツ医学)・流通経路 (病院・小売)・地域別
市場調査レポート
商品コード
991705

寒冷疼痛治療の世界市場 (~2025年):製品別の冷痛治療市場 (OTC (ジェル・クリーム・パッチ・ラップ・パッド)・処方デバイス (電動・非電動)・用途 (筋骨格・術後・スポーツ医学)・流通経路 (病院・小売)・地域別

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription Devices (Motorized, Non-Motorized), Applications (Musculoskeletal, Post Op, Sports Medicine), Distribution Channel(Hospital, Retail) - Global Forecasts to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 187 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
寒冷疼痛治療の世界市場 (~2025年):製品別の冷痛治療市場 (OTC (ジェル・クリーム・パッチ・ラップ・パッド)・処方デバイス (電動・非電動)・用途 (筋骨格・術後・スポーツ医学)・流通経路 (病院・小売)・地域別
出版日: 2021年02月25日
発行: MarketsandMarkets
ページ情報: 英文 187 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の寒冷疼痛治療の市場規模は予測期間中4.4%のCAGRで推移し、2020年の16億米ドルから、2025年には20億米ドルの規模に成長すると予測されています。

関節炎の有病率の増加、スポーツ傷害の増加などの要因が同市場の成長を推進しています。さらに、費用効果の高い製品のアベイラビリティや製品の適用の容易さについての認知度の向上も製品の導入を推進する見通しです。一方で、代替製品や代替療法の存在が市場のさらなる成長の妨げとなる可能性があります。

製品別で見ると、OTC製品の部門が予測期間中最大の成長を示すと予測されています。関節炎や他の骨格障害の高い有病率、家庭で簡単に使用できるOTC製品のアベイラビリティなどの要因が同部門の成長を牽引しています。また、用途別では、筋骨格系障害の部門が2020年に最大のシェアを示しています。骨関節炎、背中や首の痛みなどの増加、老齢人口の増加、幅広い製品のアベイラビリティなどの要因が同部門の成長を牽引しています。

当レポートでは、世界の寒冷疼痛治療の市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、価格動向、市場規模の推移・予測、製品・用途・流通経路・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • 規制状況
  • 価格動向
  • COVID-19
  • バリューチェーン分析
  • エコシステム
  • ポーターのファイブフォース分析

第6章 市場分析・予測:製品別

  • OTC製品
  • 医薬品
    • ジェル・軟膏・クリーム
    • スプレー・フォーム剤
    • パッチ
    • ロールオン
  • 医療用品
    • コールドパック
    • 冷却タオル・コンプレス・ラップ・パッド
  • 処方製品
    • 電動デバイス
    • 非電動デバイス

第7章 市場分析・予測:用途別

  • 筋骨格系障害
  • 術後
  • 外傷
  • スポーツ傷害

第8章 市場分析・予測:流通経路別

  • 院内薬局
  • 小売薬局
  • オンライン薬局

第9章 市場分析・予測:地域・主要国別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合シナリオ
  • 競合リーダーシップマッピング

第11章 企業プロファイル

  • BEIERSDORF
  • BREG, INC.
  • DJO GLOBAL, INC.
  • HISAMITSU PHARMACEUTICAL CO., INC.
  • MEDLINE INDUSTRIES
  • OSSUR
  • PERFORMANCE HEALTH
  • JOHNSON & JOHNSON
  • PFIZER
  • SANOFI
  • ROHTO PHARMACEUTICAL
  • ROMSONS GROUP OF INDUSTRIES
  • UNEXO LIFE SCIENCES
  • 3M
  • BIRD & CRONIN
  • 新興企業
    • POLAR PRODUCTS
    • RAPID AID
    • MUELLER SPORTS MEDICINE
    • PIC SOLUTION
    • BRUDER HEALTHCARE COMPANY

第12章 付録

目次
Product Code: MD 4660

The global cold pain therapy market size is projected to reach USD 2.0 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 4.4% during the forecast period. Factors such as increasing prevalence of arthritis and the rising number of sports injuries are the key factors boosting the demand for cold pain therapy products for the management of pain. Moreover, growing awareness about the availability of cost-effective cooling pain relief products and the ease of application of cold pain therapy products are anticipated to accelerate the adoption of these products in the coming years. However, presence of alternate pain relief products / therapies in the market are likely to hamper the growth of this market.

The recent COVID-19 global pandemic has also impacted the cold pain therapy market. Amid covid pandemic, the reduced access to hospital and retail pharmacies, orthopedic clinics and rehabilitation centers effected the sales growth of the cold therapy products. However, post lockdown the improved access to cold therapy devices through online platforms and the growing number of patients opting for self-medication with over-the-counter cold therapy products including cold gel packs, ointments, and cold sprays, for pain management are some of the key factors likely to drive the long-term growth of the cold pain therapy market.

"The OTC products segment to witness the highest growth rate in cold pain therapy market, by product, during the forecast period."

The OTC products segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the high prevalence of arthritis and other skeletal diorders and growing patient awareness about the availability OTC products easily to be used at home.

"The musculoskeletal disorders segment accounted for the largest share of the cold pain therapy market, by application, in 2020."

The latetal flow assays segment accounted for the largest share of the cold pain therapy market in 2020. The rise in the global prevalence of musculoskeletal disorders such as osteoarthritis, back and neck pain , growing geriatric patient population and influx of wide range of cold therapy products for musculoskeletal disorders are some of the factors anticipated to boost the segment growth in the coming years.

"The retail pharmacies segment accounted for the largest share of thecold pain therapy , by distribution channel, in 2020"

The presence of different types of cold therapy products in the retail pharamcies has played a critical role in expanding the reach to different customers. Moreover, ongoing collaborations of retail pharmacies with e-commerec marketplayers and the empahzaing on offering consulting servies to the patients are expected to some of the key factors anticipated to fuel the growth of the segment in the coming years.

"The Asia Pacific market to grow at the highest CAGR during the forecast period."

The cold pain therapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increase in the adoption of cold therapy products, increasing healthcare expenditures, increasing number of retail and hospital pharamcies in India and China, and growing collaborations among players in the region are also expected to drive pount of care diagnostics market growth in Aisa Pacific.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
  • By Designation: C-level: 26%, D-level: 30%, and Others: 44%
  • By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%

The major players operating in the cold pain therapy market are Sanofi (France), Pfizer (US), Hisamitsu Pharmaceutical (Japan), ROHTO Pharmaceutical (Japan), Beiersdorf (Germany), Johnson & Johnson (US), Medline Industries (US), Ossur (Iceland), Performance Health (US), Breg (US), Romsons Group of Industries (India), Unexo Life Sciences (India), and Bird & Cronin (US).

Research Coverage

This report studies the cold pain therapy market based on the product, application, distribution challenge, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the cold pain therapy market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MAJOR MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: COLD PAIN THERAPY MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 APPLICATION-BASED MARKET ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: COLD PAIN THERAPY MARKET
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 6 COLD PAIN THERAPY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 7 COLD PAIN THERAPY MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE COLD PAIN THERAPY MARKET

4 PREMIUM INSIGHTS

  • 4.1 COLD PAIN THERAPY MARKET OVERVIEW
    • FIGURE 10 RISING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE MARKET GROWTH
  • 4.2 COLD PAIN THERAPY MARKET, BY PRODUCT, 2020
    • FIGURE 11 OTC PRODUCTS SEGMENT TO DOMINATE THE COLD PAIN THERAPY MARKET IN 2020
  • 4.3 ASIA PACIFIC COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL AND COUNTRY
    • FIGURE 12 RETAIL PHARMACIES FORMED THE LARGEST DISTRIBUTION CHANNEL SEGMENT IN THE APAC COLD PAIN THERAPY MARKET IN 2020
  • 4.4 COLD PAIN THERAPY MARKET, BY REGION
    • FIGURE 13 APAC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2020-2025)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 14 COLD PAIN THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of sports injuries and rising emphasis on exercise and gym activities
      • 5.2.1.2 Growing number of hip and knee surgeries across the globe
      • 5.2.1.3 Rising geriatric population and subsequent growth in the prevalence of bone diseases and trauma injuries
      • 5.2.1.4 Growing need for safer pain management modalities as opposed to oral drug therapy
      • 5.2.1.5 Clinical evidence in favor of menthol-based topical analgesics
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High usage of low-priced analgesic pills for immediate pain relief
      • 5.2.2.2 Lack of reimbursement
      • 5.2.2.3 Lack of substantial clinical evidence in favor of cold pain therapy
      • 5.2.2.4 Health hazards and discomfort associated with cold pain therapy products
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing adoption of analgesic patches
      • 5.2.3.2 Growing use of cold pain therapy among middle-aged women
      • 5.2.3.3 Increasing regulatory barriers for oral pain medications
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Availability of alternative non-drug/device pain management therapies
  • 5.3 GLOBAL REGULATORY LANDSCAPE
  • 5.4 PRICING TREND ANALYSIS
    • TABLE 1 COLD PAIN THERAPY PRODUCTS PRICING, BY COUNTRY, 2019 (USD)
  • 5.5 INDUSTRY TRENDS RELATED TO COVID-19
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 15 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING THE REGULATION AND DISTRIBUTION STAGES
  • 5.7 ECOSYSTEM COVERAGE: PARENT MARKET (ORTHOPEDIC DEVICES MARKET)
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 COLD PAIN THERAPY MARKET: PORTER'S FIVE FORCES ANALYSIS

6 COLD PAIN THERAPY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 3 COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • 6.2 OTC PRODUCTS
    • TABLE 4 COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 5 COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 6 COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • TABLE 7 COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY REGION, 2018-2025 (USD MILLION)
  • 6.3 PHARMACEUTICALS
    • TABLE 8 COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 9 COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 10 COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • TABLE 11 COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.1 GELS, OINTMENTS, AND CREAMS
      • 6.3.1.1 Gels, ointments, and creams offer effective orthopedic pain management therapy over oral drugs
    • TABLE 12 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 13 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 14 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • 6.3.2 SPRAYS AND FOAMS
      • 6.3.2.1 Procedural benefits offered by sprays and foams to increase their adoption among sportspersons
    • TABLE 15 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 16 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 17 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • 6.3.3 PATCHES
      • 6.3.3.1 Ability to deliver a consistent dosage of drug over topical creams is resulting in the greater consumption of cold pain patches
    • TABLE 18 COLD PAIN THERAPY MARKET FOR PATCHES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 19 COLD PAIN THERAPY MARKET FOR PATCHES, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 20 COLD PAIN THERAPY MARKET FOR PATCHES, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • 6.3.4 ROLL-ONS
      • 6.3.4.1 Inconsistent drug delivery and the need for repetitive usage on the skin are expected to hamper their adoption
    • TABLE 21 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 22 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 23 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
  • 6.4 MEDICAL DEVICES
    • TABLE 24 COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 25 COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 26 COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • TABLE 27 COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY REGION, 2018-2025 (USD MILLION)
    • 6.4.1 COLD PACKS
      • 6.4.1.1 Cold packs are among the widely used cold pain therapy medical devices
    • TABLE 28 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 29 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • TABLE 30 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY REGION, 2018-2025 (USD MILLION)
    • 6.4.2 COOLING TOWELS, COMPRESSES, WRAPS, AND PADS
      • 6.4.2.1 Growing availability of wraps and cooling pads to aid the growth of this market segment
    • TABLE 31 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 32 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 33 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
  • 6.5 PRESCRIPTION PRODUCTS
    • TABLE 34 COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 35 COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 36 COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • TABLE 37 COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY REGION, 2018-2025 (USD MILLION)
    • 6.5.1 MOTORIZED DEVICES
      • 6.5.1.1 Preference for motorized devices is increasing among patients
    • TABLE 38 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 39 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • TABLE 40 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY REGION, 2018-2025 (USD MILLION)
    • 6.5.2 NON-MOTORIZED DEVICES
      • 6.5.2.1 Non-motorized devices cost lower as compared to motorized devices
    • TABLE 41 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 42 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • TABLE 43 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY REGION, 2018-2025 (USD MILLION)

7 COLD PAIN THERAPY MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 44 COLD PAIN THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 7.2 MUSCULOSKELETAL DISORDERS
    • 7.2.1 INCREASING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 45 COLD PAIN THERAPY MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 POST-OPERATIVE THERAPY
    • 7.3.1 INCREASING NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 46 COLD PAIN THERAPY MARKET FOR POST-OPERATIVE THERAPY, BY REGION, 2018-2025 (USD MILLION)
  • 7.4 POST-TRAUMA THERAPY
    • 7.4.1 INCREASING INCIDENCE OF TRAUMA INJURIES TO PROPEL THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 47 COLD PAIN THERAPY MARKET FOR POST-TRAUMA THERAPY, BY REGION, 2018-2025 (USD MILLION)
  • 7.5 SPORTS INJURIES
    • 7.5.1 GROWING NUMBER OF SPORTS INJURIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 48 COLD PAIN THERAPY MARKET FOR SPORTS MEDICINE, BY REGION, 2018-2025 (USD MILLION)

8 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL

  • 8.1 INTRODUCTION
    • TABLE 49 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
  • 8.2 HOSPITAL PHARMACIES
    • 8.2.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 50 COLD PAIN THERAPY MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 RETAIL PHARMACIES
    • 8.3.1 RETAIL PHARMACIES FORM THE LARGEST DISTRIBUTION CHANNEL FOR COLD PAIN THERAPY PRODUCTS
    • TABLE 51 COLD PAIN THERAPY MARKET FOR RETAIL PHARMACIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 E-PHARMACIES
    • 8.4.1 E-PHARMACIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
    • TABLE 52 COLD PAIN THERAPY MARKET FOR E-PHARMACIES, BY REGION, 2018-2025 (USD MILLION)

9 COLD PAIN THERAPY MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 53 COLD PAIN THERAPY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 16 NORTH AMERICA: COLD PAIN THERAPY MARKET SNAPSHOT
    • TABLE 54 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 55 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 56 NORTH AMERICA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 57 NORTH AMERICA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 58 NORTH AMERICA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 59 NORTH AMERICA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 60 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 61 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Strong presence of market players has driven market growth in the US
    • TABLE 62 US: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 63 US: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 64 US: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 65 US: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 66 US: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Market growth is driven by the rising number of hip and knee replacement surgeries
    • TABLE 67 CANADA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 68 CANADA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 69 CANADA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 70 CANADA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 71 CANADA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 72 EUROPE: COLD PAIN THERAPY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 73 EUROPE: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 74 EUROPE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 75 EUROPE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 76 EUROPE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 77 EUROPE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 78 EUROPE: COLD PAIN THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 79 EUROPE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Rising investments to drive market growth in Germany
    • TABLE 80 GERMANY: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 81 GERMANY: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 82 GERMANY: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 83 GERMANY: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 84 GERMANY: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Market growth in the UK is mainly driven by the increasing prevalence of musculoskeletal conditions
    • TABLE 85 UK: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 86 UK: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 87 UK: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 88 UK: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 89 UK: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Increasing target patient population to drive market growth in France
    • TABLE 90 FRANCE: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 91 FRANCE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 92 FRANCE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 93 FRANCE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 94 FRANCE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Growing public awareness about the preventive care of musculoskeletal disorders to drive market growth
    • TABLE 95 ITALY: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 96 ITALY: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 97 ITALY: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 98 ITALY: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 99 ITALY: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing prevalence of target diseases to drive market growth
    • TABLE 100 SPAIN: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 101 SPAIN: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 102 SPAIN: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 103 SPAIN: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 104 SPAIN: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 105 NUMBER OF SURGERIES CONDUCTED IN ROE COUNTRIES
    • TABLE 106 REST OF EUROPE: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 107 REST OF EUROPE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 108 REST OF EUROPE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 109 REST OF EUROPE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 110 REST OF EUROPE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 17 ASIA PACIFIC: COLD PAIN THERAPY MARKET SNAPSHOT
    • TABLE 111 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 115 ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Japan dominates the Asia Pacific cold pain therapy market
    • TABLE 119 JAPAN: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 120 JAPAN: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 121 JAPAN: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 122 JAPAN: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 123 JAPAN: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Expansion in the target patient population to drive market growth
    • TABLE 124 CHINA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 125 CHINA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 126 CHINA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 127 CHINA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 128 CHINA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Growing number of arthritis cases to drive market growth
    • TABLE 129 INDIA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 130 INDIA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 131 INDIA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 132 INDIA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 133 INDIA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Rising prevalence of target diseases to drive market growth
    • TABLE 134 AUSTRALIA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 135 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 136 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 137 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 138 AUSTRALIA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.4.5 SOUTH KOREA
      • 9.4.5.1 Supportive government initiatives expected to positively impact market growth
    • TABLE 139 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 140 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 141 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 142 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 143 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.4.6 REST OF ASIA PACIFIC
    • TABLE 144 REST OF ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 145 REST OF ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 146 REST OF ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 147 REST OF ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 148 REST OF ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 149 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 150 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 151 LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 152 LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 153 LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 154 LATIN AMERICA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 155 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 156 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
    • 9.5.1 BRAZIL
      • 9.5.1.1 Growing obese population will drive market growth in Brazil
    • TABLE 157 BRAZIL: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 158 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 159 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 160 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 161 BRAZIL: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.5.2 MEXICO
      • 9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
    • TABLE 162 MEXICO: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 163 MEXICO: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 164 MEXICO: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 165 MEXICO: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 166 MEXICO: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • 9.5.3 REST OF LATIN AMERICA
    • TABLE 167 REST OF LATIN AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 168 REST OF LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 169 REST OF LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 170 REST OF LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 171 REST OF LATIN AMERICA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 AWARENESS INITIATIVES TO DRIVE THE ADOPTION OF COLD PAIN THERAPY IN THE REGION
    • TABLE 172 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 173 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 174 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 175 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 176 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 177 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 178 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 18 KEY DEVELOPMENTS IN THE COLD PAIN THERAPY MARKET (2017-2020)
  • 10.2 MARKET SHARE ANALYSIS (2019)
    • FIGURE 19 SANOFI HELD THE LEADING POSITION IN THE MARKET IN 2019
  • 10.3 COMPETITIVE SCENARIO (2016-2020)
    • FIGURE 20 STRATEGIC OVERVIEW: MAJOR PLAYERS (2016-2020)
    • 10.3.1 KEY PRODUCT LAUNCHES AND PRODUCT APPROVALS (2016-2020)
    • 10.3.2 KEY EXPANSIONS AND ACQUISITIONS (2016-2020)
    • 10.3.3 KEY AGREEMENTS, CONTRACTS, AND PARTNERSHIPS (2016-2020)
  • 10.4 COMPETITIVE LEADERSHIP MAPPING: MAJOR GLOBAL PLAYERS (AS OF 2019)
    • 10.4.1 STARS
    • 10.4.2 EMERGING LEADERS
    • 10.4.3 PERVASIVE PLAYERS
    • 10.4.4 PARTICIPANTS
    • FIGURE 21 COLD PAIN THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019 (MAJOR GLOBAL PLAYERS)
  • 10.5 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/ SMES/START-UPS (AS OF 2019)
    • 10.5.1 PROGRESSIVE COMPANIES
    • 10.5.2 STARTING BLOCKS
    • 10.5.3 RESPONSIVE COMPANIES
    • 10.5.4 DYNAMIC COMPANIES
    • FIGURE 22 COLD PAIN THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019 (MAJOR SMES/START-UPS)

11 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)**
  • 11.1 BEIERSDORF
    • FIGURE 23 BEIERSDORF: COMPANY SNAPSHOT
  • 11.2 BREG, INC.
  • 11.3 DJO GLOBAL, INC.
    • FIGURE 24 COLFAX CORPORATION: COMPANY SNAPSHOT
  • 11.4 HISAMITSU PHARMACEUTICAL CO., INC.
    • FIGURE 25 HISAMITSU PHARMACEUTICAL CO, INC.: COMPANY SNAPSHOT
  • 11.5 MEDLINE INDUSTRIES
  • 11.6 OSSUR
    • FIGURE 26 OSSUR: COMPANY SNAPSHOT
  • 11.7 PERFORMANCE HEALTH
  • 11.8 JOHNSON & JOHNSON
    • FIGURE 27 JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • 11.9 PFIZER
    • FIGURE 28 PFIZER: COMPANY SNAPSHOT
  • 11.10 SANOFI
    • FIGURE 29 SANOFI: COMPANY SNAPSHOT
  • 11.11 ROHTO PHARMACEUTICAL
    • FIGURE 30 ROHTO PHARMACEUTICAL: COMPANY SNAPSHOT
  • 11.12 ROMSONS GROUP OF INDUSTRIES
  • 11.13 UNEXO LIFE SCIENCES
  • 11.14 3M
    • FIGURE 31 3M: COMPANY SNAPSHOT
  • 11.15 BIRD & CRONIN
  • 11.16 EMERGING PLAYERS
    • 11.16.1 POLAR PRODUCTS
    • 11.16.2 RAPID AID
    • 11.16.3 MUELLER SPORTS MEDICINE
    • 11.16.4 PIC SOLUTION
    • 11.16.5 BRUDER HEALTHCARE COMPANY
  • *Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS